The pharma and biotech CRM software market size has grown rapidly in recent years. It will grow from $6.26 billion in 2023 to $7.39 billion in 2024 at a compound annual growth rate (CAGR) of 18.1%. The growth observed in the historical period can be attributed to several factors, including a transition towards a customer-centric approach, the expansion of sales and marketing channels, heightened demand for data analytics, a greater emphasis on efficiency and productivity, and a focus on enhancing the overall customer experience.
The pharma and biotech CRM software market size is expected to see rapid growth in the next few years. It will grow to $14.46 billion in 2028 at a compound annual growth rate (CAGR) of 18.3%. The anticipated growth in the forecast period can be attributed to several key factors, including the emphasis on AI-powered customer insight, the expansion of virtual engagement solutions, integration with the healthcare ecosystem, ensuring compliance and data security, and the increasing demand for mobile and remote access. Major trends expected to shape the forecast period include the proliferation of AI-powered customer insights, predictive analytics tailored for healthcare providers, the adoption of a patient-centric approach, the rise of virtual engagement solutions, and a heightened focus on digital marketing strategies.
The escalating demand for personalized medicine is set to drive the growth of the pharma and biotech CRM software market in the foreseeable future. Personalized medicine, a healthcare approach tailored to individual patients based on their genetic makeup, environmental factors, and lifestyle, is gaining traction due to the rising prevalence of chronic diseases and cancer among populations. This growing demand for customized medical solutions necessitates the utilization of pharma and biotech CRM software to efficiently manage patient data, track treatment outcomes, and facilitate personalized healthcare delivery. For instance, as reported by the Personalized Medicine Coalition, 12 new personalized medications were approved in 2022, constituting approximately 34% of all newly approved treatments, signifying a substantial increase compared to previous years. Consequently, the surge in demand for personalized medicine emerges as a key driver propelling the growth of the pharma and biotech CRM software market.
Leading players in the pharma and biotech CRM software market are increasingly integrating artificial intelligence (AI) and machine learning capabilities into their platforms, such as the AI-powered personalized engagement platform, to cater to the evolving needs of the pharmaceutical and biotechnology sectors. AI-powered personalized engagement empowers companies to deliver targeted and relevant messaging to healthcare professionals (HCPs), patients, and other stakeholders. For instance, in October 2023, Salesforce, Inc., a prominent US-based provider of cloud-based software solutions, unveiled its life sciences cloud, designed to streamline patient engagement and clinical operations through data-driven automation and trusted AI. This innovative solution enables pharmaceutical and medical technology organizations to enhance patient engagement, optimize clinical operations, manage commercial lifecycles, and deliver personalized stakeholder experiences throughout the drug and device development journey.
In January 2024, Nomadia, a France-based provider of cloud-based SaaS solutions, acquired Nomadvantage for an undisclosed sum. This strategic acquisition underscores Nomadia's commitment to expanding its portfolio of cloud-based SaaS solutions and bolstering its market presence. Nomadvantage, also based in France, specializes in customer relations management software tailored to the healthcare and pharmaceutical industries, aligning with Nomadia's strategic vision to offer comprehensive solutions to meet the evolving needs of its clients in these sectors.
Major companies operating in the pharma and biotech crm software market are Oracle Corporation, Salesforce.com Inc., IQVIA Holdings Inc., Trueblue Inc., Cirrius Solutions Inc., Veeva Systems Inc., Aurea Software Inc., Indegene Private Limited, Close-Up International Limited, Interactive Medica S.A., StayinFront Inc., Axtria Inc., Navicon Consulting LLC, Aktana Inc., Bpmonline, AKA Enterprise Solutions LLC, Anthill Agency Ltd., Media-Soft Inc., Zephyr Health Inc., Synergistix Inc., Euris S.A., Inova Software Inc., Prolifiq Software Inc., Infonis International Corp., Ivy Software Development Services Pvt. Ltd.
North America was the largest region in the pharma and biotech CRM software market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma and biotech crm software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharma and biotech crm software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Pharma and biotech CRM software is a specialized solution tailored to aid pharmaceutical and biotech companies in effectively managing customer relationships, data, and interactions. This tool is instrumental in facilitating a seamless and personalized customer experience, empowering organizations to nurture stronger relationships by gaining comprehensive insights into customer interactions.
The primary technology categories for pharma and biotech CRM software encompass artificial intelligence customer relationship management (CRM) and conventional customer relationship management (CRM). AI-driven CRM software for pharma and biotech leverages artificial intelligence and machine learning algorithms to analyze customer data, deliver valuable insights, and automate various tasks. These software solutions are deployed via on-premises or cloud-based models, catering to the needs of both large enterprises and small to medium enterprises (SMEs) operating within the pharmaceutical and biotech industries.
The pharma and biotech CRM software market research report is one of a series of new reports that provides pharma and biotech CRM software market statistics, including pharma and biotech CRM software industry global market size, regional shares, competitors with a pharma and biotech CRM software market share, detailed pharma and biotech CRM software market segments, market trends and opportunities, and any further data you may need to thrive in the pharma and biotech CRM software industry. This pharma and biotech CRM software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharma and biotech CRM software market consists of revenues earned by entities through services such as customer relationship management, sales force automation, marketing automation, mobile and remote access, and integration with the healthcare ecosystem. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma and biotech CRM market also includes sales of lead management software, email marketing software, call centre software, event management software, and training and education software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The pharma and biotech CRM software market size is expected to see rapid growth in the next few years. It will grow to $14.46 billion in 2028 at a compound annual growth rate (CAGR) of 18.3%. The anticipated growth in the forecast period can be attributed to several key factors, including the emphasis on AI-powered customer insight, the expansion of virtual engagement solutions, integration with the healthcare ecosystem, ensuring compliance and data security, and the increasing demand for mobile and remote access. Major trends expected to shape the forecast period include the proliferation of AI-powered customer insights, predictive analytics tailored for healthcare providers, the adoption of a patient-centric approach, the rise of virtual engagement solutions, and a heightened focus on digital marketing strategies.
The escalating demand for personalized medicine is set to drive the growth of the pharma and biotech CRM software market in the foreseeable future. Personalized medicine, a healthcare approach tailored to individual patients based on their genetic makeup, environmental factors, and lifestyle, is gaining traction due to the rising prevalence of chronic diseases and cancer among populations. This growing demand for customized medical solutions necessitates the utilization of pharma and biotech CRM software to efficiently manage patient data, track treatment outcomes, and facilitate personalized healthcare delivery. For instance, as reported by the Personalized Medicine Coalition, 12 new personalized medications were approved in 2022, constituting approximately 34% of all newly approved treatments, signifying a substantial increase compared to previous years. Consequently, the surge in demand for personalized medicine emerges as a key driver propelling the growth of the pharma and biotech CRM software market.
Leading players in the pharma and biotech CRM software market are increasingly integrating artificial intelligence (AI) and machine learning capabilities into their platforms, such as the AI-powered personalized engagement platform, to cater to the evolving needs of the pharmaceutical and biotechnology sectors. AI-powered personalized engagement empowers companies to deliver targeted and relevant messaging to healthcare professionals (HCPs), patients, and other stakeholders. For instance, in October 2023, Salesforce, Inc., a prominent US-based provider of cloud-based software solutions, unveiled its life sciences cloud, designed to streamline patient engagement and clinical operations through data-driven automation and trusted AI. This innovative solution enables pharmaceutical and medical technology organizations to enhance patient engagement, optimize clinical operations, manage commercial lifecycles, and deliver personalized stakeholder experiences throughout the drug and device development journey.
In January 2024, Nomadia, a France-based provider of cloud-based SaaS solutions, acquired Nomadvantage for an undisclosed sum. This strategic acquisition underscores Nomadia's commitment to expanding its portfolio of cloud-based SaaS solutions and bolstering its market presence. Nomadvantage, also based in France, specializes in customer relations management software tailored to the healthcare and pharmaceutical industries, aligning with Nomadia's strategic vision to offer comprehensive solutions to meet the evolving needs of its clients in these sectors.
Major companies operating in the pharma and biotech crm software market are Oracle Corporation, Salesforce.com Inc., IQVIA Holdings Inc., Trueblue Inc., Cirrius Solutions Inc., Veeva Systems Inc., Aurea Software Inc., Indegene Private Limited, Close-Up International Limited, Interactive Medica S.A., StayinFront Inc., Axtria Inc., Navicon Consulting LLC, Aktana Inc., Bpmonline, AKA Enterprise Solutions LLC, Anthill Agency Ltd., Media-Soft Inc., Zephyr Health Inc., Synergistix Inc., Euris S.A., Inova Software Inc., Prolifiq Software Inc., Infonis International Corp., Ivy Software Development Services Pvt. Ltd.
North America was the largest region in the pharma and biotech CRM software market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma and biotech crm software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharma and biotech crm software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Pharma and biotech CRM software is a specialized solution tailored to aid pharmaceutical and biotech companies in effectively managing customer relationships, data, and interactions. This tool is instrumental in facilitating a seamless and personalized customer experience, empowering organizations to nurture stronger relationships by gaining comprehensive insights into customer interactions.
The primary technology categories for pharma and biotech CRM software encompass artificial intelligence customer relationship management (CRM) and conventional customer relationship management (CRM). AI-driven CRM software for pharma and biotech leverages artificial intelligence and machine learning algorithms to analyze customer data, deliver valuable insights, and automate various tasks. These software solutions are deployed via on-premises or cloud-based models, catering to the needs of both large enterprises and small to medium enterprises (SMEs) operating within the pharmaceutical and biotech industries.
The pharma and biotech CRM software market research report is one of a series of new reports that provides pharma and biotech CRM software market statistics, including pharma and biotech CRM software industry global market size, regional shares, competitors with a pharma and biotech CRM software market share, detailed pharma and biotech CRM software market segments, market trends and opportunities, and any further data you may need to thrive in the pharma and biotech CRM software industry. This pharma and biotech CRM software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharma and biotech CRM software market consists of revenues earned by entities through services such as customer relationship management, sales force automation, marketing automation, mobile and remote access, and integration with the healthcare ecosystem. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma and biotech CRM market also includes sales of lead management software, email marketing software, call centre software, event management software, and training and education software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Pharma and Biotech CRM Software Market Characteristics3. Pharma and Biotech CRM Software Market Trends and Strategies32. Global Pharma and Biotech CRM Software Market Competitive Benchmarking33. Global Pharma and Biotech CRM Software Market Competitive Dashboard34. Key Mergers and Acquisitions in the Pharma and Biotech CRM Software Market
4. Pharma and Biotech CRM Software Market - Macro Economic Scenario
5. Global Pharma and Biotech CRM Software Market Size and Growth
6. Pharma and Biotech CRM Software Market Segmentation
7. Pharma and Biotech CRM Software Market Regional and Country Analysis
8. Asia-Pacific Pharma and Biotech CRM Software Market
9. China Pharma and Biotech CRM Software Market
10. India Pharma and Biotech CRM Software Market
11. Japan Pharma and Biotech CRM Software Market
12. Australia Pharma and Biotech CRM Software Market
13. Indonesia Pharma and Biotech CRM Software Market
14. South Korea Pharma and Biotech CRM Software Market
15. Western Europe Pharma and Biotech CRM Software Market
16. UK Pharma and Biotech CRM Software Market
17. Germany Pharma and Biotech CRM Software Market
18. France Pharma and Biotech CRM Software Market
19. Italy Pharma and Biotech CRM Software Market
20. Spain Pharma and Biotech CRM Software Market
21. Eastern Europe Pharma and Biotech CRM Software Market
22. Russia Pharma and Biotech CRM Software Market
23. North America Pharma and Biotech CRM Software Market
24. USA Pharma and Biotech CRM Software Market
25. Canada Pharma and Biotech CRM Software Market
26. South America Pharma and Biotech CRM Software Market
27. Brazil Pharma and Biotech CRM Software Market
28. Middle East Pharma and Biotech CRM Software Market
29. Africa Pharma and Biotech CRM Software Market
30. Pharma and Biotech CRM Software Market Competitive Landscape and Company Profiles
31. Pharma and Biotech CRM Software Market Other Major and Innovative Companies
35. Pharma and Biotech CRM Software Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Pharma and Biotech CRM Software Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on pharma and biotech CRM software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pharma and biotech CRM software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma and biotech CRM software market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Technology: Artificial Intelligence Customer Relationship Management (CRM); Conventional Customer Relationship Management (CRM)2) by Deployment: on-Premises; Cloud Based
3) by Enterprise Size: Large Enterprise; Small and Medium Enterprise (SMEs)
4) by Industry: Pharmaceuticals; Biotech
Key Companies Mentioned: Oracle Corporation; Salesforce.com Inc.; IQVIA Holdings Inc.; Trueblue Inc.; Cirrius Solutions Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Oracle Corporation
- Salesforce.com Inc.
- IQVIA Holdings Inc.
- Trueblue Inc.
- Cirrius Solutions Inc.
- Veeva Systems Inc.
- Aurea Software Inc.
- Indegene Private Limited
- Close-Up International Limited
- Interactive Medica S.A.
- StayinFront Inc.
- Axtria Inc.
- Navicon Consulting LLC
- Aktana Inc.
- Bpmonline
- AKA Enterprise Solutions LLC
- Anthill Agency Ltd.
- Media-Soft Inc.
- Zephyr Health Inc.
- Synergistix Inc.
- Euris S.A.
- Inova Software Inc.
- Prolifiq Software Inc.
- Infonis International Corp.
- Ivy Software Development Services Pvt. Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | July 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 7.39 Billion |
| Forecasted Market Value ( USD | $ 14.46 Billion |
| Compound Annual Growth Rate | 18.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
